Search - tctmd.com

Displaying 81 - 100 of 262

Sort: Relevancy | Date

Presentation TCT 2024

TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Presenter: Batla Falah

October 28, 2024

Presentation TCT 2024

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

Presenter: Amir Kaki

October 27, 2024

Presentation TCT 2024

Impact of Bleeding Complications on Clinical Outcomes in Patients Undergoing Impella Support in Cardiogenic Shock

Presenter: Lene Holmvang

October 27, 2024

Presentation TCT 2024

TCT 457: Resource Utilization Associated With Impella Versus Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock Patients

Presenter: Margriet Bogerd

October 27, 2024

Presentation TCT 2024

TCT 407: Clinical Characteristics and Outcomes of Impella Supported High-Risk Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion: Insights From the cVAD PROTECT III Registry

Presenter: Batla Falah

October 27, 2024

Presentation TCT 2024

TCT 1107: Impella CP® Blocked in the Left Ventricular Outflow Tract: The Solution Is a Transseptal One

Presenter: Zuzana Hudcovská

October 27, 2024

Presentation TCT 2024

TCT 66: Similar Short and Long-Term Outcomes in Patients Undergoing Impella-Supported Left Main PCI With and Without Severe Calcifications: Insights From the National Polish IMPELLA-PL Registry

Presenter: Tomasz Pawlowski

October 27, 2024

Presentation Interventional Complications 2024

Large Bore Access in a Hurry: How to Place Impella, ECMO, or Tandem Safely in Crashing Patient

Presenter: Alexander Truesdell

August 02, 2024

Presentation Interventional Complications 2024

How to Safely Remove Large Bore Devices: ECMO/Distal Perfusion Cannulae/Impella/MCS

Presenter: Jeremy Rier

August 02, 2024

Presentation Interventional Complications 2024

Large Device Fracture! Getting Out the Impella Remnants or Other Large Broken Equipment

Presenter: Sanjog Kalra

August 02, 2024

Presentation NY Valves 2024

Impella-Assisted TAV in TAV in SAV for Acute Cardiogenic Shock

Presenter: Wally Omar

June 06, 2024

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT Abstracts 2024

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Presenter: Brent Medoff

March 04, 2024

Advertisement

TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

Impact of Bleeding Complications on Clinical Outcomes in Patients Undergoing Impella Support in Cardiogenic Shock

TCT 457: Resource Utilization Associated With Impella Versus Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock Patients

TCT 407: Clinical Characteristics and Outcomes of Impella Supported High-Risk Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion: Insights From the cVAD PROTECT III Registry

TCT 1107: Impella CP® Blocked in the Left Ventricular Outflow Tract: The Solution Is a Transseptal One

TCT 66: Similar Short and Long-Term Outcomes in Patients Undergoing Impella-Supported Left Main PCI With and Without Severe Calcifications: Insights From the National Polish IMPELLA-PL Registry

Large Bore Access in a Hurry: How to Place Impella, ECMO, or Tandem Safely in Crashing Patient

How to Safely Remove Large Bore Devices: ECMO/Distal Perfusion Cannulae/Impella/MCS

Large Device Fracture! Getting Out the Impella Remnants or Other Large Broken Equipment

Impella-Assisted TAV in TAV in SAV for Acute Cardiogenic Shock

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content